Will Flanigan
Impact in
-
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
-
- Long-Term Effects of COVID-19
Papers in
-
- SARS-CoV-2 and COVID-19 Research 1
-
- Mitochondrial Function and Pathology 1
- Co-authors
- Huihui Li (1 shared paper)Todd C. McDevitt (1 shared paper)Michael S. Kang (1 shared paper)Peiyi Chen (1 shared paper)Sarah J. Rockwood (1 shared paper)Paul Hanson (1 shared paper)Bruce R. Conklin (1 shared paper)Juan A. Pérez-Bermejo (1 shared paper)
- Journals
- Science Translational Medicine (1 paper)APL Bioengineering (1 paper)BMC Cancer (1 paper)Nature Cardiovascular Research (1 paper)
- Partner nations
- United StatesCanada
In The Last Decade
Will Flanigan
4 papers receiving 169 citations
Peers
Comparison fields: 5 of 52
- Infectious Diseases 90
- Neurology 45
- Oncology 36
- Reproductive Medicine 10
- Cardiology and Cardiovascular Medicine 24
Countries citing papers authored by Will Flanigan
This map shows the geographic impact of Will Flanigan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Will Flanigan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Will Flanigan more than expected).
Fields of papers citing papers by Will Flanigan
This network shows the impact of papers produced by Will Flanigan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Will Flanigan. The network helps show where Will Flanigan may publish in the future.
Co-authors
The 23 scholars most cited alongside Will Flanigan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 130 | |
| 2 | 2018 | 27 | |
| 3 | 2020 | 8 | |
| 4 | 2022 | 5 |
About Will Flanigan
Will Flanigan is a scholar working on Infectious Diseases, Molecular Biology, Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Oncology, having authored 4 papers that have together received 170 indexed citations. Recurring topics across this work include Cardiac electrophysiology and arrhythmias (1 paper), Ovarian function and disorders (1 paper), PARP inhibition in cancer therapy (1 paper), Ovarian cancer diagnosis and treatment (1 paper), SARS-CoV-2 and COVID-19 Research (1 paper), Reproductive System and Pregnancy (1 paper), Mitochondrial Function and Pathology (1 paper) and Respiratory Support and Mechanisms (1 paper). The work is most often cited by research in Infectious Diseases (90 citations), Neurology (45 citations), Oncology (36 citations), Reproductive Medicine (10 citations) and Cardiology and Cardiovascular Medicine (24 citations). Will Flanigan has collaborated with scholars based in United States and Canada. Frequent co-authors include Huihui Li, Todd C. McDevitt, Michael S. Kang, Peiyi Chen, Sarah J. Rockwood, Paul Hanson, Bruce R. Conklin, Juan A. Pérez-Bermejo, Parinaz Fozouni and Jeffrey D. Whitman. Their work appears in journals such as Science Translational Medicine, APL Bioengineering, BMC Cancer and Nature Cardiovascular Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.